{
    "id": 24567,
    "fullName": "MEF2D - BCL9",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MEF2D - BCL9 results from the fusion of MEF2D and BCL9, which leads to increased transcriptional activity and is transforming in cell culture (PMID: 27019113).",
            "references": [
                {
                    "id": 6335,
                    "pubMedId": 27019113,
                    "title": "Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27019113"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4209,
        "geneSymbol": "MEF2D",
        "terms": [
            "MEF2D"
        ]
    },
    "variant": "MEF2D - BCL9",
    "createDate": "07/19/2016",
    "updateDate": "11/20/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 607,
                "geneSymbol": "BCL9",
                "terms": [
                    "BCL9",
                    "LGS"
                ]
            }
        }
    ],
    "evidence": [
        
    ],
    "molecularProfiles": [
        {
            "id": 25315,
            "profileName": "MEF2D - BCL9",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}